Home > Insider Trading > Filing (0001179110-12-013911)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1034842	Rigel Pharmaceuticals Inc	RIGL	Pharmaceutical Preparations (2834)	943248524

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363984	D Ryan Maynard	Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080	Evp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-09-07	34,112	$6.49	34,112	No	4	M	Direct
Common Stock	Disposition	2012-09-07	34,112	$10.55	0	No	4	S	Direct
Common Stock	Acquisiton	2012-09-10	17,586	$6.49	17,586	No	4	M	Direct
Common Stock	Disposition	2012-09-10	17,586	$10.52	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-09-07	34,112	$0.00	34,112	$6.49
Common Stock	Stock Option (Right to Buy)	Disposition	2012-09-10	17,586	$0.00	17,586	$6.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
114,188		2019-03-30	No	4	M	Direct
96,602		2019-03-30	No	4	M	Direct

Footnotes

The shares vest month over one(1) year from 3/30/09.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.76, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.57, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote (3) of this Form 4.